490.4K XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Paul F. Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 4,544 | 30,805 | - | - | Stock Options (Right to Buy) | |
| James Intrater | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 4,544 | 30,805 | - | - | Stock Options (Right to Buy) | |
| Paul F. Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 18,686 | 26,261 | - | - | Stock Options (Right to Buy) | |
| Stanley K. Lau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 18,686 | 26,261 | - | - | Stock Options (Right to Buy) | |
| James Intrater | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 18,686 | 26,261 | - | - | Stock Options (Right to Buy) | |
| Oded Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 18,686 | 26,261 | - | - | Stock Options (Right to Buy) | |
| Robert Philibert | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 06 Sep 2024 | 7,460 | 1,683,867 | - | 0.3 | 2,125 | Common Stock |
| Meeshanthini V. Dogan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 68,965 | 197,310 | - | 0.3 | 20,000 | Common Stock |
| Meeshanthini V. Dogan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 68,965 | 1,683,867 | - | 0.3 | 20,000 | Common Stock |
| Robert Philibert | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 26,615 | 1,676,407 | - | 0.3 | 7,639 | Common Stock |
| Timur Dogan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 68,965 | 197,310 | - | 0.3 | 20,000 | Common Stock |
| Meeshanthini V. Dogan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 68,965 | 1,655,429 | - | 0.3 | 20,000 | Common Stock |
| Meeshanthini V. Dogan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 68,965 | 1,655,429 | - | 0.3 | 20,000 | Common Stock |
| Timur Dogan | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 06 Sep 2024 | 68,965 | 197,310 | - | 0.3 | 20,000 | Common Stock |
| Paul F. Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 7,575 | 7,575 | - | - | Stock Options (Right to Buy) | |
| Stanley K. Lau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 7,575 | 7,575 | - | - | Stock Options (Right to Buy) | |
| James Intrater | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 7,575 | 7,575 | - | - | Stock Options (Right to Buy) | |
| Oded Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 7,575 | 7,575 | - | - | Stock Options (Right to Buy) | |
| Paul F. Burton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 31 Mar 2024 | 8,803 | 8,803 | - | 1.4 | 12,500 | Common Stock |
| Stanley K. Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 31 Mar 2024 | 8,803 | 100,325 | - | 1.4 | 12,500 | Common Stock |
| James Intrater | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 31 Mar 2024 | 8,803 | 71,596 | - | 1.4 | 12,500 | Common Stock |
| Oded Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 31 Mar 2024 | 8,803 | 71,596 | - | 1.4 | 12,500 | Common Stock |
| Lau Stanley K. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.18 per share. | 31 Jan 2024 | 917 | 91,522 | - | 2.2 | 1,999 | Common Stock |
| Warren Hosseinion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 35,719 | 502,195 | - | - | Stock Options (Right to Buy) | |
| Luqman Elisa | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 35,719 | 264,832 | - | - | Stock Options (Right to Buy) | |
| Meeshanthini Dogan V. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 238,128 | 435,467 | - | - | Stock Options (Right to Buy) | |
| Abdullahi Khullani | VP of Revenue and Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 238,128 | 304,128 | - | - | Stock Options (Right to Buy) | |
| Dogan Timur | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 238,128 | 435,467 | - | - | Stock Options (Right to Buy) | |
| Dogan Timur | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 476,256 | 1,433,958 | - | - | Stock Options (Right to Buy) | |
| Robert Philibert | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 142,876 | 805,465 | - | - | Stock Options (Right to Buy) | |
| Meeshanthini Dogan V. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 476,256 | 1,433,958 | - | - | Stock Options (Right to Buy) | |
| Sim Brandon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 31 Dec 2023 | 5,020 | 62,793 | - | 2.5 | 12,500 | Common Stock |
| Lau K. Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 31 Dec 2023 | 1,606 | 85,585 | - | 2.5 | 3,999 | Common Stock |
| James Intrater | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 31 Dec 2023 | 5,020 | 62,793 | - | 2.5 | 12,500 | Common Stock |
| Levy Oded | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 31 Dec 2023 | 5,020 | 62,793 | - | 2.5 | 12,500 | Common Stock |
| Lau Stanley K. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 31 Dec 2023 | 5,020 | 90,605 | - | 2.5 | 12,500 | Common Stock |
| Brandon Sim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 30 Jun 2023 | 21,008 | 21,008 | - | 1.2 | 25,000 | Common Stock |
| Oded Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 30 Jun 2023 | 21,008 | 21,008 | - | 1.2 | 25,000 | Common Stock |
| James Intrater | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 30 Jun 2023 | 21,008 | 21,208 | - | 1.2 | 25,000 | Common Stock |
| Stanley K. Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 30 Jun 2023 | 8,403 | 29,411 | - | 1.2 | 10,000 | Common Stock |
| Stanley K. Lau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 30 Jun 2023 | 21,008 | 21,008 | - | 1.2 | 25,000 | Common Stock |
| Meeshanthini Dogan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 157,570 | 157,750 | - | - | Stock Options (Right to Buy) | |
| Meeshanthini Dogan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 272,250 | 272,250 | - | - | Stock Options (Right to Buy) | |
| Elisa Luqman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 57,750 | 57,750 | - | - | Stock Options (Right to Buy) | |
| Warren Hosseinion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 123,750 | 123,750 | - | - | Stock Options (Right to Buy) | |
| Robert Philibert | Director, Chief Medical Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 148,500 | 148,500 | - | - | Stock Options (Right to Buy) | |
| Timur Dogan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 272,250 | 272,250 | - | - | Stock Options (Right to Buy) | |
| Timur Dogan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 157,750 | 157,750 | - | - | Stock Options (Right to Buy) | |
| Khullani Abdullahi | VP of Revenue and Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 66,000 | 66,000 | - | - | Stock Options (Right to Buy) |